세계의 의약품 무균 검사 시장 : 시장 규모, 점유율 및 동향 분석 - 유형별, 제품 유형별, 샘플별, 최종 용도별, 검사 유형별, 지역별 전망 및 예측(2023-2030년)

The Global Pharmaceutical Sterility Testing Market size is expected to reach $3.1 billion by 2030, rising at a market growth of 10.7% CAGR during the forecast period.

Advances in medical technology have led to the development of increasingly complex medical devices. Consequently, the medical device companies by end-use would generate approximately 21.6% share in the market by 2030. The complexity of these devices may require more sophisticated sterility testing methodologies to ensure their safety and efficacy. This complexity can drive the demand for specialized sterility testing services tailored to the unique characteristics of medical devices.

Health authorities, including the FDA and EMA, maintain a global pharmaceutical quality and safety perspective. The regulatory frameworks established by these bodies set the benchmark for sterility testing requirements. As a result, pharmaceutical manufacturers must align their processes with these standards to navigate the complex landscape of international regulatory compliance. Hence, owing to these factors, there will be increased demand for pharmaceutical sterility testing.

Additionally, Patient safety is a top priority in healthcare, and any compromise in the sterility of pharmaceutical products can pose serious risks to patients. Infections resulting from contaminated drugs or medical devices can lead to adverse health outcomes and increased healthcare costs. Thus, these factors will fuel the demand for pharmaceuticals in the upcoming years.

However, Regulatory bodies, such as the United States Pharmacopeia (USP) and the European Pharmacopoeia (EP), enforce stringent guidelines for sterility testing to ensure the safety and efficacy of pharmaceutical products. Hence, these factors can lead to reduced demand in the pharmaceutical market.

Furthermore, the increased demand for these products emphasized the need for rigorous sterility testing procedures to guarantee their safety and effectiveness. The pandemic necessitated expedited timelines for developing, testing, and approving pharmaceutical products, including vaccines. Hence, the COVID-19 pandemic positively impacted the pharmaceutical market.

By Type Analysis

Based on type, the market is segmented into in-house and outsourcing. In 2022, the outsourcing segment held 59% revenue share in the market. Outsourcing sterility testing offers cost-efficiency benefits. Establishing and maintaining an in-house sterility testing facility involves substantial capital investment, ongoing operational costs, and the need for skilled personnel. Hence, these factors will help in the expansion of the segment.

By Product Type Analysis

On the basis of product, the market is divided into kits & reagents, instruments, and services. In 2022, the instruments segment witnessed a 25% revenue share in the market. Technological advances have led to the development of sophisticated instruments that offer improved capabilities for sterility testing. Automated systems, robotics, and advanced analytical instruments contribute to the overall efficiency of testing processes, allowing for faster and more accurate detection of microbial contaminants. Therefore, these factors can drive the expansion of the segment.

By Sample Analysis

Based on sample, the market is segmented into pharmaceuticals, medical devices, and biopharmaceuticals. The pharmaceuticals segment held the 46% revenue share in the market in 2022. Many pharmaceutical companies increasingly outsource manufacturing and testing activities to contract service providers. This trend can contribute to the growth of the market, with contract testing laboratories playing a key role in providing sterility testing services. Therefore, these factors can lead to enhanced demand in the segment.

By End Use Analysis

On the basis of end-use, the market is divided into compounding pharmacies, medical device companies, pharmaceutical companies, and others. The compounding pharmacies segment recorded an 11% revenue share in the market in 2022. Compounding pharmacies customize medications to meet the unique needs of individual patients. They are crucial in providing tailored solutions for patients requiring specific formulations, dosages, or delivery methods not readily available in commercially manufactured medications. Hence, these factors will pose lucrative growth prospects for the segment.

By Test Type Analysis

Based on test type, the market is divided into sterility testing, bioburden Testing, and bacterial endotoxin testing. In 2022, the bioburden testing segment recorded 42.5% revenue share in the market. Bioburden testing plays a key role in meeting regulatory requirements and ensuring compliance with quality standards. Regulatory agencies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have strict guidelines for controlling microbial contamination in pharmaceutical products. Thus, these factors can assist in the expansion of the segment.

By Regional Analysis

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. In 2022, the Europe segment acquired a 26.17% revenue share in the market. Europe has a well-established pharmaceutical industry with a diverse range of products. The continuous growth of the pharmaceutical sector, including the development of new drugs and biologics, contributes to the demand for sterility testing to ensure product safety and efficacy. Therefore, these factors will pose lucrative growth prospects for the segment.

Recent Strategies Deployed in the Market

• Feb-2024: Thermo Fisher Scientific, Inc. expanded its footprints in Asia-Pacific with the inauguration of a sterile drug facility in Singapore. Through this expansion, Thermo Fisher will facilitate end-to-end vaccine manufacturing in Singapore, thereby fortifying its vaccine supply chain resilience and enhancing future pandemic preparedness for the region.
• Feb-2024: Charles River Laboratories International, Inc. launched the Endosafe Trillium rCR cartridge, an animal-free testing solution, to expand its robust bacterial endotoxin testing (BET) portfolio. The endosafe trillium rCR will enhance testing efficiency and accelerate manufacturing.
• May-2023: Charles River Laboratories International, Inc. unveiled Accugenix Next Generation Sequencing (Accugenix NGS) for bacterial and fungal identification. Accugenix NGS will enable the company to deliver swift and precise results while fostering stronger technical collaboration with biotech and pharma customers.
• Mar-2023: Pace Analytical Services, LLC, completed the acquisition of Alpha Analytical, LLC, a full-service environmental laboratory services company. Through this acquisition, Pace will broaden its presence and bring essential services closer to businesses and communities in the Northeastern United States.
• Sep-2019: Charles River Laboratories International, Inc. expanded its microbial solutions suite by launching the EndoScan-V software platform and the Celsis automated detection solution. EndoScan-V is a validation software for detecting and measuring endotoxins that generates and reports quantitative test data. Celsis will provide automated sterility results within 6 days, enabling manufacturers to promptly confirm the presence or absence of microbial contamination.

List of Key Companies Profiled

• Steris PLC
• Charles River Laboratories International, Inc.
• Thermo Fisher Scientific, Inc.
• SGS S.A.
• Sartorius AG
• Sotera Health Company
• Pacific Biolabs, Inc.
• Laboratory Corporation of America Holdings
• Almac Group
• Pace Analytical Services, LLC

Global Pharmaceutical Sterility Testing Market Report Segmentation

By Type

• Outsourcing
• In-House

By Product Type

• Kits & Reagents
• Instruments
• Services

By Sample

• Pharmaceuticals
• Medical Devices
• Biopharmaceuticals

By End Use

• Pharmaceutical Companies
• Medical Device Companies
• Compounding Pharmacies
• Others

By Test Type

• Bioburden Testing
• Sterility Testing
• Bacterial Endotoxin Testing

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

• 1.1Market Definition
• 1.2Objectives
• 1.3Market Scope
• 1.4Segmentation
  • 1.4.1Global Pharmaceutical Sterility Testing Market, by Type
  • 1.4.2Global Pharmaceutical Sterility Testing Market, by Product Type
  • 1.4.3Global Pharmaceutical Sterility Testing Market, by Sample
  • 1.4.4Global Pharmaceutical Sterility Testing Market, by End Use
  • 1.4.5Global Pharmaceutical Sterility Testing Market, by Test Type
  • 1.4.6Global Pharmaceutical Sterility Testing Market, by Geography
• 1.5Methodology for the research

Chapter 2.Market at a Glance

• 2.1Key Highlights

Chapter 3.Market Overview

• 3.1Introduction
  • 3.1.1Overview
    • 3.1.1.1Market Composition and Scenario
• 3.2Key Factors Impacting the Market
  • 3.2.1Market Drivers
  • 3.2.2Market Restraints
  • 3.2.3Market Opportunities
  • 3.2.4Market Challenges
• 3.3Porter's Five Forces Analysis

Chapter 4.Global Pharmaceutical Sterility Testing Market by Type

• 4.1Global Outsourcing Market by Region
• 4.2Global In-House Market by Region

Chapter 5.Global Pharmaceutical Sterility Testing Market by Product Type

• 5.1Global Kits & Reagents Market by Region
• 5.2Global Instruments Market by Region
• 5.3Global Services Market by Region

Chapter 6.Global Pharmaceutical Sterility Testing Market by Sample

• 6.1Global Pharmaceuticals Market by Region
• 6.2Global Medical Devices Market by Region
• 6.3Global Biopharmaceuticals Market by Region

Chapter 7.Global Pharmaceutical Sterility Testing Market by End-use

• 7.1Global Pharmaceutical Companies Market by Region
• 7.2Global Medical Device Companies Market by Region
• 7.3Global Compounding Pharmacies Market by Region
• 7.4Global Others Market by Region

Chapter 8.Global Pharmaceutical Sterility Testing Market by Test Type

• 8.1Global Bioburden Testing Market by Region
• 8.2Global Sterility Testing Market by Region
• 8.3Global Bacterial Endotoxin Testing Market by Region

Chapter 9.Global Pharmaceutical Sterility Testing Market by Region

• 9.1North America Pharmaceutical Sterility Testing Market
  • 9.1.1North America Pharmaceutical Sterility Testing Market by Type
    • 9.1.1.1North America Outsourcing Market by Region
    • 9.1.1.2North America In-House Market by Region
  • 9.1.2North America Pharmaceutical Sterility Testing Market by Product Type
    • 9.1.2.1North America Kits & Reagents Market by Country
    • 9.1.2.2North America Instruments Market by Country
    • 9.1.2.3North America Services Market by Country
  • 9.1.3North America Pharmaceutical Sterility Testing Market by Sample
    • 9.1.3.1North America Pharmaceuticals Market by Country
    • 9.1.3.2North America Medical Devices Market by Country
    • 9.1.3.3North America Biopharmaceuticals Market by Country
  • 9.1.4North America Pharmaceutical Sterility Testing Market by End-use
    • 9.1.4.1North America Pharmaceutical Companies Market by Country
    • 9.1.4.2North America Medical Device Companies Market by Country
    • 9.1.4.3North America Compounding Pharmacies Market by Country
    • 9.1.4.4North America Others Market by Country
  • 9.1.5North America Pharmaceutical Sterility Testing Market by Test Type
    • 9.1.5.1North America Bioburden Testing Market by Country
    • 9.1.5.2North America Sterility Testing Market by Country
    • 9.1.5.3North America Bacterial Endotoxin Testing Market by Country
  • 9.1.6North America Pharmaceutical Sterility Testing Market by Country
    • 9.1.6.1US Pharmaceutical Sterility Testing Market
      • 9.1.6.1.1US Pharmaceutical Sterility Testing Market by Type
      • 9.1.6.1.2US Pharmaceutical Sterility Testing Market by Product Type
      • 9.1.6.1.3US Pharmaceutical Sterility Testing Market by Sample
      • 9.1.6.1.4US Pharmaceutical Sterility Testing Market by End-use
      • 9.1.6.1.5US Pharmaceutical Sterility Testing Market by Test Type
    • 9.1.6.2Canada Pharmaceutical Sterility Testing Market
      • 9.1.6.2.1Canada Pharmaceutical Sterility Testing Market by Type
      • 9.1.6.2.2Canada Pharmaceutical Sterility Testing Market by Product Type
      • 9.1.6.2.3Canada Pharmaceutical Sterility Testing Market by Sample
      • 9.1.6.2.4Canada Pharmaceutical Sterility Testing Market by End-use
      • 9.1.6.2.5Canada Pharmaceutical Sterility Testing Market by Test Type
    • 9.1.6.3Mexico Pharmaceutical Sterility Testing Market
      • 9.1.6.3.1Mexico Pharmaceutical Sterility Testing Market by Type
      • 9.1.6.3.2Mexico Pharmaceutical Sterility Testing Market by Product Type
      • 9.1.6.3.3Mexico Pharmaceutical Sterility Testing Market by Sample
      • 9.1.6.3.4Mexico Pharmaceutical Sterility Testing Market by End-use
      • 9.1.6.3.5Mexico Pharmaceutical Sterility Testing Market by Test Type
    • 9.1.6.4Rest of North America Pharmaceutical Sterility Testing Market
      • 9.1.6.4.1Rest of North America Pharmaceutical Sterility Testing Market by Type
      • 9.1.6.4.2Rest of North America Pharmaceutical Sterility Testing Market by Product Type
      • 9.1.6.4.3Rest of North America Pharmaceutical Sterility Testing Market by Sample
      • 9.1.6.4.4Rest of North America Pharmaceutical Sterility Testing Market by End-use
      • 9.1.6.4.5Rest of North America Pharmaceutical Sterility Testing Market by Test Type
• 9.2Europe Pharmaceutical Sterility Testing Market
  • 9.2.1Europe Pharmaceutical Sterility Testing Market by Type
    • 9.2.1.1Europe Outsourcing Market by Country
    • 9.2.1.2Europe In-House Market by Country
  • 9.2.2Europe Pharmaceutical Sterility Testing Market by Product Type
    • 9.2.2.1Europe Kits & Reagents Market by Country
    • 9.2.2.2Europe Instruments Market by Country
    • 9.2.2.3Europe Services Market by Country
  • 9.2.3Europe Pharmaceutical Sterility Testing Market by Sample
    • 9.2.3.1Europe Pharmaceuticals Market by Country
    • 9.2.3.2Europe Medical Devices Market by Country
    • 9.2.3.3Europe Biopharmaceuticals Market by Country
  • 9.2.4Europe Pharmaceutical Sterility Testing Market by End-use
    • 9.2.4.1Europe Pharmaceutical Companies Market by Country
    • 9.2.4.2Europe Medical Device Companies Market by Country
    • 9.2.4.3Europe Compounding Pharmacies Market by Country
    • 9.2.4.4Europe Others Market by Country
  • 9.2.5Europe Pharmaceutical Sterility Testing Market by Test Type
    • 9.2.5.1Europe Bioburden Testing Market by Country
    • 9.2.5.2Europe Sterility Testing Market by Country
    • 9.2.5.3Europe Bacterial Endotoxin Testing Market by Country
  • 9.2.6Europe Pharmaceutical Sterility Testing Market by Country
    • 9.2.6.1Germany Pharmaceutical Sterility Testing Market
      • 9.2.6.1.1Germany Pharmaceutical Sterility Testing Market by Type
      • 9.2.6.1.2Germany Pharmaceutical Sterility Testing Market by Product Type
      • 9.2.6.1.3Germany Pharmaceutical Sterility Testing Market by Sample
      • 9.2.6.1.4Germany Pharmaceutical Sterility Testing Market by End-use
      • 9.2.6.1.5Germany Pharmaceutical Sterility Testing Market by Test Type
    • 9.2.6.2UK Pharmaceutical Sterility Testing Market
      • 9.2.6.2.1UK Pharmaceutical Sterility Testing Market by Type
      • 9.2.6.2.2UK Pharmaceutical Sterility Testing Market by Product Type
      • 9.2.6.2.3UK Pharmaceutical Sterility Testing Market by Sample
      • 9.2.6.2.4UK Pharmaceutical Sterility Testing Market by End-use
      • 9.2.6.2.5UK Pharmaceutical Sterility Testing Market by Test Type
    • 9.2.6.3France Pharmaceutical Sterility Testing Market
      • 9.2.6.3.1France Pharmaceutical Sterility Testing Market by Type
      • 9.2.6.3.2France Pharmaceutical Sterility Testing Market by Product Type
      • 9.2.6.3.3France Pharmaceutical Sterility Testing Market by Sample
      • 9.2.6.3.4France Pharmaceutical Sterility Testing Market by End-use
      • 9.2.6.3.5France Pharmaceutical Sterility Testing Market by Test Type
    • 9.2.6.4Russia Pharmaceutical Sterility Testing Market
      • 9.2.6.4.1Russia Pharmaceutical Sterility Testing Market by Type
      • 9.2.6.4.2Russia Pharmaceutical Sterility Testing Market by Product Type
      • 9.2.6.4.3Russia Pharmaceutical Sterility Testing Market by Sample
      • 9.2.6.4.4Russia Pharmaceutical Sterility Testing Market by End-use
      • 9.2.6.4.5Russia Pharmaceutical Sterility Testing Market by Test Type
    • 9.2.6.5Spain Pharmaceutical Sterility Testing Market
      • 9.2.6.5.1Spain Pharmaceutical Sterility Testing Market by Type
      • 9.2.6.5.2Spain Pharmaceutical Sterility Testing Market by Product Type
      • 9.2.6.5.3Spain Pharmaceutical Sterility Testing Market by Sample
      • 9.2.6.5.4Spain Pharmaceutical Sterility Testing Market by End-use
      • 9.2.6.5.5Spain Pharmaceutical Sterility Testing Market by Test Type
    • 9.2.6.6Italy Pharmaceutical Sterility Testing Market
      • 9.2.6.6.1Italy Pharmaceutical Sterility Testing Market by Type
      • 9.2.6.6.2Italy Pharmaceutical Sterility Testing Market by Product Type
      • 9.2.6.6.3Italy Pharmaceutical Sterility Testing Market by Sample
      • 9.2.6.6.4Italy Pharmaceutical Sterility Testing Market by End-use
      • 9.2.6.6.5Italy Pharmaceutical Sterility Testing Market by Test Type
    • 9.2.6.7Rest of Europe Pharmaceutical Sterility Testing Market
      • 9.2.6.7.1Rest of Europe Pharmaceutical Sterility Testing Market by Type
      • 9.2.6.7.2Rest of Europe Pharmaceutical Sterility Testing Market by Product Type
      • 9.2.6.7.3Rest of Europe Pharmaceutical Sterility Testing Market by Sample
      • 9.2.6.7.4Rest of Europe Pharmaceutical Sterility Testing Market by End-use
      • 9.2.6.7.5Rest of Europe Pharmaceutical Sterility Testing Market by Test Type
• 9.3Asia Pacific Pharmaceutical Sterility Testing Market
  • 9.3.1Asia Pacific Pharmaceutical Sterility Testing Market by Type
    • 9.3.1.1Asia Pacific Outsourcing Market by Country
    • 9.3.1.2Asia Pacific In-House Market by Country
  • 9.3.2Asia Pacific Pharmaceutical Sterility Testing Market by Product Type
    • 9.3.2.1Asia Pacific Kits & Reagents Market by Country
    • 9.3.2.2Asia Pacific Instruments Market by Country
    • 9.3.2.3Asia Pacific Services Market by Country
  • 9.3.3Asia Pacific Pharmaceutical Sterility Testing Market by Sample
    • 9.3.3.1Asia Pacific Pharmaceuticals Market by Country
    • 9.3.3.2Asia Pacific Medical Devices Market by Country
    • 9.3.3.3Asia Pacific Biopharmaceuticals Market by Country
  • 9.3.4Asia Pacific Pharmaceutical Sterility Testing Market by End-use
    • 9.3.4.1Asia Pacific Pharmaceutical Companies Market by Country
    • 9.3.4.2Asia Pacific Medical Device Companies Market by Country
    • 9.3.4.3Asia Pacific Compounding Pharmacies Market by Country
    • 9.3.4.4Asia Pacific Others Market by Country
  • 9.3.5Asia Pacific Pharmaceutical Sterility Testing Market by Test Type
    • 9.3.5.1Asia Pacific Bioburden Testing Market by Country
    • 9.3.5.2Asia Pacific Sterility Testing Market by Country
    • 9.3.5.3Asia Pacific Bacterial Endotoxin Testing Market by Country
  • 9.3.6Asia Pacific Pharmaceutical Sterility Testing Market by Country
    • 9.3.6.1China Pharmaceutical Sterility Testing Market
      • 9.3.6.1.1China Pharmaceutical Sterility Testing Market by Type
      • 9.3.6.1.2China Pharmaceutical Sterility Testing Market by Product Type
      • 9.3.6.1.3China Pharmaceutical Sterility Testing Market by Sample
      • 9.3.6.1.4China Pharmaceutical Sterility Testing Market by End-use
      • 9.3.6.1.5China Pharmaceutical Sterility Testing Market by Test Type
    • 9.3.6.2Japan Pharmaceutical Sterility Testing Market
      • 9.3.6.2.1Japan Pharmaceutical Sterility Testing Market by Type
      • 9.3.6.2.2Japan Pharmaceutical Sterility Testing Market by Product Type
      • 9.3.6.2.3Japan Pharmaceutical Sterility Testing Market by Sample
      • 9.3.6.2.4Japan Pharmaceutical Sterility Testing Market by End-use
      • 9.3.6.2.5Japan Pharmaceutical Sterility Testing Market by Test Type
    • 9.3.6.3India Pharmaceutical Sterility Testing Market
      • 9.3.6.3.1India Pharmaceutical Sterility Testing Market by Type
      • 9.3.6.3.2India Pharmaceutical Sterility Testing Market by Product Type
      • 9.3.6.3.3India Pharmaceutical Sterility Testing Market by Sample
      • 9.3.6.3.4India Pharmaceutical Sterility Testing Market by End-use
      • 9.3.6.3.5India Pharmaceutical Sterility Testing Market by Test Type
    • 9.3.6.4South Korea Pharmaceutical Sterility Testing Market
      • 9.3.6.4.1South Korea Pharmaceutical Sterility Testing Market by Type
      • 9.3.6.4.2South Korea Pharmaceutical Sterility Testing Market by Product Type
      • 9.3.6.4.3South Korea Pharmaceutical Sterility Testing Market by Sample
      • 9.3.6.4.4South Korea Pharmaceutical Sterility Testing Market by End-use
      • 9.3.6.4.5South Korea Pharmaceutical Sterility Testing Market by Test Type
    • 9.3.6.5Singapore Pharmaceutical Sterility Testing Market
      • 9.3.6.5.1Singapore Pharmaceutical Sterility Testing Market by Type
      • 9.3.6.5.2Singapore Pharmaceutical Sterility Testing Market by Product Type
      • 9.3.6.5.3Singapore Pharmaceutical Sterility Testing Market by Sample
      • 9.3.6.5.4Singapore Pharmaceutical Sterility Testing Market by End-use
      • 9.3.6.5.5Singapore Pharmaceutical Sterility Testing Market by Test Type
    • 9.3.6.6Malaysia Pharmaceutical Sterility Testing Market
      • 9.3.6.6.1Malaysia Pharmaceutical Sterility Testing Market by Type
      • 9.3.6.6.2Malaysia Pharmaceutical Sterility Testing Market by Product Type
      • 9.3.6.6.3Malaysia Pharmaceutical Sterility Testing Market by Sample
      • 9.3.6.6.4Malaysia Pharmaceutical Sterility Testing Market by End-use
      • 9.3.6.6.5Malaysia Pharmaceutical Sterility Testing Market by Test Type
    • 9.3.6.7Rest of Asia Pacific Pharmaceutical Sterility Testing Market
      • 9.3.6.7.1Rest of Asia Pacific Pharmaceutical Sterility Testing Market by Type
      • 9.3.6.7.2Rest of Asia Pacific Pharmaceutical Sterility Testing Market by Product Type
      • 9.3.6.7.3Rest of Asia Pacific Pharmaceutical Sterility Testing Market by Sample
      • 9.3.6.7.4Rest of Asia Pacific Pharmaceutical Sterility Testing Market by End-use
      • 9.3.6.7.5Rest of Asia Pacific Pharmaceutical Sterility Testing Market by Test Type
• 9.4LAMEA Pharmaceutical Sterility Testing Market
  • 9.4.1LAMEA Pharmaceutical Sterility Testing Market by Type
    • 9.4.1.1LAMEA Outsourcing Market by Country
    • 9.4.1.2LAMEA In-House Market by Country
  • 9.4.2LAMEA Pharmaceutical Sterility Testing Market by Product Type
    • 9.4.2.1LAMEA Kits & Reagents Market by Country
    • 9.4.2.2LAMEA Instruments Market by Country
    • 9.4.2.3LAMEA Services Market by Country
  • 9.4.3LAMEA Pharmaceutical Sterility Testing Market by Sample
    • 9.4.3.1LAMEA Pharmaceuticals Market by Country
    • 9.4.3.2LAMEA Medical Devices Market by Country
    • 9.4.3.3LAMEA Biopharmaceuticals Market by Country
  • 9.4.4LAMEA Pharmaceutical Sterility Testing Market by End-use
    • 9.4.4.1LAMEA Pharmaceutical Companies Market by Country
    • 9.4.4.2LAMEA Medical Device Companies Market by Country
    • 9.4.4.3LAMEA Compounding Pharmacies Market by Country
    • 9.4.4.4LAMEA Others Market by Country
  • 9.4.5LAMEA Pharmaceutical Sterility Testing Market by Test Type
    • 9.4.5.1LAMEA Bioburden Testing Market by Country
    • 9.4.5.2LAMEA Sterility Testing Market by Country
    • 9.4.5.3LAMEA Bacterial Endotoxin Testing Market by Country
  • 9.4.6LAMEA Pharmaceutical Sterility Testing Market by Country
    • 9.4.6.1Brazil Pharmaceutical Sterility Testing Market
      • 9.4.6.1.1Brazil Pharmaceutical Sterility Testing Market by Type
      • 9.4.6.1.2Brazil Pharmaceutical Sterility Testing Market by Product Type
      • 9.4.6.1.3Brazil Pharmaceutical Sterility Testing Market by Sample
      • 9.4.6.1.4Brazil Pharmaceutical Sterility Testing Market by End-use
      • 9.4.6.1.5Brazil Pharmaceutical Sterility Testing Market by Test Type
    • 9.4.6.2Argentina Pharmaceutical Sterility Testing Market
      • 9.4.6.2.1Argentina Pharmaceutical Sterility Testing Market by Type
      • 9.4.6.2.2Argentina Pharmaceutical Sterility Testing Market by Product Type
      • 9.4.6.2.3Argentina Pharmaceutical Sterility Testing Market by Sample
      • 9.4.6.2.4Argentina Pharmaceutical Sterility Testing Market by End-use
      • 9.4.6.2.5Argentina Pharmaceutical Sterility Testing Market by Test Type
    • 9.4.6.3UAE Pharmaceutical Sterility Testing Market
      • 9.4.6.3.1UAE Pharmaceutical Sterility Testing Market by Type
      • 9.4.6.3.2UAE Pharmaceutical Sterility Testing Market by Product Type
      • 9.4.6.3.3UAE Pharmaceutical Sterility Testing Market by Sample
      • 9.4.6.3.4UAE Pharmaceutical Sterility Testing Market by End-use
      • 9.4.6.3.5UAE Pharmaceutical Sterility Testing Market by Test Type
    • 9.4.6.4Saudi Arabia Pharmaceutical Sterility Testing Market
      • 9.4.6.4.1Saudi Arabia Pharmaceutical Sterility Testing Market by Type
      • 9.4.6.4.2Saudi Arabia Pharmaceutical Sterility Testing Market by Product Type
      • 9.4.6.4.3Saudi Arabia Pharmaceutical Sterility Testing Market by Sample
      • 9.4.6.4.4Saudi Arabia Pharmaceutical Sterility Testing Market by End-use
      • 9.4.6.4.5Saudi Arabia Pharmaceutical Sterility Testing Market by Test Type
    • 9.4.6.5South Africa Pharmaceutical Sterility Testing Market
      • 9.4.6.5.1South Africa Pharmaceutical Sterility Testing Market by Type
      • 9.4.6.5.2South Africa Pharmaceutical Sterility Testing Market by Product Type
      • 9.4.6.5.3South Africa Pharmaceutical Sterility Testing Market by Sample
      • 9.4.6.5.4South Africa Pharmaceutical Sterility Testing Market by End-use
      • 9.4.6.5.5South Africa Pharmaceutical Sterility Testing Market by Test Type
    • 9.4.6.6Nigeria Pharmaceutical Sterility Testing Market
      • 9.4.6.6.1Nigeria Pharmaceutical Sterility Testing Market by Type
      • 9.4.6.6.2Nigeria Pharmaceutical Sterility Testing Market by Product Type
      • 9.4.6.6.3Nigeria Pharmaceutical Sterility Testing Market by Sample
      • 9.4.6.6.4Nigeria Pharmaceutical Sterility Testing Market by End-use
      • 9.4.6.6.5Nigeria Pharmaceutical Sterility Testing Market by Test Type
    • 9.4.6.7Rest of LAMEA Pharmaceutical Sterility Testing Market
      • 9.4.6.7.1Rest of LAMEA Pharmaceutical Sterility Testing Market by Type
      • 9.4.6.7.2Rest of LAMEA Pharmaceutical Sterility Testing Market by Product Type
      • 9.4.6.7.3Rest of LAMEA Pharmaceutical Sterility Testing Market by Sample
      • 9.4.6.7.4Rest of LAMEA Pharmaceutical Sterility Testing Market by End-use
      • 9.4.6.7.5Rest of LAMEA Pharmaceutical Sterility Testing Market by Test Type

Chapter 10.Company Profiles

• 10.1Steris PLC
  • 10.1.1Company Overview
  • 10.1.2Financial Analysis
  • 10.1.3Segmental and Regional Analysis
  • 10.1.4Research & Development Expenses
  • 10.1.5SWOT Analysis
• 10.2Charles River Laboratories International, Inc.
  • 10.2.1Company Overview
  • 10.2.2Financial Analysis
  • 10.2.3Segmental and Regional Analysis
  • 10.2.4Recent strategies and developments:
    • 10.2.4.1Product Launches and Product Expansions:
  • 10.2.5SWOT Analysis
• 10.3Thermo Fisher Scientific, Inc.
  • 10.3.1Company Overview
  • 10.3.2Financial Analysis
  • 10.3.3Segmental and Regional Analysis
  • 10.3.4Research & Development Expenses
  • 10.3.5Recent strategies and developments:
    • 10.3.5.1Geographical Expansions:
  • 10.3.6SWOT Analysis
• 10.4SGS S.A.
  • 10.4.1Company Overview
  • 10.4.2Financial Analysis
  • 10.4.3Segmental Analysis
  • 10.4.4SWOT Analysis
• 10.5Sartorius AG
  • 10.5.1Company Overview
  • 10.5.2Financial Analysis
  • 10.5.3Segmental and Regional Analysis
  • 10.5.4Research & Development Expenses
  • 10.5.5Recent strategies and developments:
    • 10.5.5.1Partnerships, Collaborations, and Agreements:
  • 10.5.6SWOT Analysis
• 10.6Sotera Health Company
  • 10.6.1Company Overview
  • 10.6.2Financial Analysis
  • 10.6.3Segmental and Regional Analysis
  • 10.6.4SWOT Analysis
• 10.7Pacific Biolabs, Inc.
  • 10.7.1Company Overview
  • 10.7.2SWOT Analysis
• 10.8Laboratory Corporation of America Holdings
  • 10.8.1Company Overview
  • 10.8.2Financial Analysis
  • 10.8.3Segmental and Regional Analysis
  • 10.8.4SWOT Analysis
• 10.9Almac group
  • 10.9.1Company Overview
  • 10.9.2SWOT Analysis
• 10.10.Pace Analytical Services, LLC
  • 10.10.1Company Overview
  • 10.10.2Recent strategies and developments:
    • 10.10.2.1Acquisition and Mergers:
  • 10.10.3SWOT Analysis

Chapter 11.Winning Imperatives of Pharmaceutical Sterility Testing Market